Novel multidrug resistance reversal agents

Journal of Medicinal Chemistry

Volumn 42, Issue 12, 1999, Pages 2145-2161

  Berger, Dan ^a   Citarella, Ron ^a   Dutia, Minu ^a   Greenberger, Lee ^a   Hallett, William ^a   Paul, Rolf ^a   Powell, Dennis ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOINDOLE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOQUINOLINES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NITRILES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0033578034     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9804477     Document Type: Article

References (46)

1. Young, R. C. Drug resistance: the clinical problem. In Drug Resistance in Cancer Therapy; Ozols, R. F., Ed.; Kluwer Academic Press: Boston, 1989; pp 1-12.
2. Pratt, W. B. In Principles of Drug Action. The Basis of Pharmacology; Pratt, W. B., Ed.; Churchill Livingstone: New York, 1990; pp 565-638.
3. Endicott, J. A.; Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 1989, 58, 137-171.
4. Gottesman, M. M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
5. Goldstein, L. J.; Galski, H.; Fojo, A.; Willingham, M.; Lai, S. L.; Gazdak, A.; Pirker, R.; Cossman, J.; Gottesman, M. M.; Pastan, I. Expression of multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 1989, 81, 116-124.
6. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981, 41, 1967-1972.
7. Tsuruo, T. Circumvention of drug resistance with calcium channel blockers and monoclonal antibodies. In Drug Resistance in Cancer Therapy; Ozols, E. R. F., Ed.; Kluwer Academic Press: Boston, 1989; pp 73-95.
8. Nogae, I.; Kohno, K.; Kikuchi, J.; Kuwano, M.; Akiyama, S.; Kiue, A.; Suzuki, K.; Yoshida, Y.; Cornwell, M. M.; Pastan, I.; Gottesman, M. M. Analysis of structural features of dihydropyridine analogues needed to reverse multidrug resistance and to inhibit the photoaffinity labeling of P-glycoprotein. Biochem. Pharmacol. 1989, 38, 519-528.
9. Shudo, N.; Mizoguchi, T.; Arita, M.; Yoshimura, A.; Seto, K.; Sakoda, R.; Akiyama, S. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Cancer Res. 1990, 50, 3055-3061.
10. Zamora, J. M.; Pearce, H. L.; Beck, W. T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 1988, 33, 454-462.
11. Tsuruo, T.; Iida, H.; Kitatani, Y.; Yokota, K.; Tsukagoshi, S.; Sakurai, Y. Effects of quinidine and related compounds on cytotoxicity and cellular concentration of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res. 1984, 44, 4303-4307.
12. Slater, L. M.; Sweet, P.; Stupecky, M.; Gupta, S. Cyclosporine A reverses vincristine and daunorubicin resistance in acute lymphocytic leukemia in vitro. J. Clin. Invest. 1986, 77, 1405-1408.
13. Kuntebommanahalli, N. T.; Horton, J. K.; Seshadri, R.; Israel, M.; Houghton, J. A.; Harwood, F. C.; Houghton, P. J. Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cells. J. Med. Chem. 1992, 35, 3358-3364.
14. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982, 42, 4730-4733.
15. Dhainaut, A.; Regnier, G.; Atassi, G.; Pierre, A.; Leonce, S.; Kraus-Berthier, L.; Prost, J.-F. New triazine derivatives as potent modulators of multidrug resistance. J. Med. Chem. 1992, 35, 2481-2496.
16. Hyafil, F.; Vergely, C.; Duvignaud, P.; Grandperret, T. In vitro and in vivo reversal of multidrug resistance by GF-120918, an acridonecarboxamide derivative. Cancer Res. 1993, 53, 4595-4602.
17. Germann, U. A.; Zelle, R. E.; Shlyakhter, D.; et al. VX-710: A novel agent for reversal of P-glycoprotein-mediated multidrug resistance. Proc. Am. Assoc. Cancer Res. 1995, 36, 346.
18. Shinoda, H.; Inaba, M.; Tsuruo, T. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52. Cancer Res. 1989, 49, 1722-1726.
19. Pirker, R.; Keilhauer, G.; Raschack, M.; Lechner, C.; Ludwig, H. Reversal of multidrug resistance in human KB cell lines by structural analogues of verapamil. Int. J. Cancer 1990, 45, 916-919.
20. Toffoli, G.; Simone, F.; Corona, G.; Raschack, M.; Cappelleto, B.; Gigante, M.; Boiocchi, M. Structure - activity relationship of verapamil analogues and reversal of multidrug resistance. Biochem. Pharmacol. 1995, 50, 1245-1255.
21. Boesch, D.; Gaveriaux, C.; Jachnes, B.; Poutier-Manzanedo, A.; Bollinger, P.; Loor, F. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumors with SDZ PSC 833. Cancer Res. 1961, 51, 4226-4233.
22. Robert, J. Multidrug resistance reversal agents. Drugs Future 1997, 22, 149-158.
23. Carhart, R. E.; Smith, D. H.; Venkataraghavan, R. Atom Pairs as Molecular Features in Structure-Activity Studies: Definition and Applications. J. Chem. Inf. Comput. Sci. 1985, 25, 64-73.
24. Wood, J. H.; Perry, M. A.; Tung, C. C. The Bis-chloromethylation of Aromatic Compounds. J. Am. Chem. Soc. 1950, 72, 2989.
25. Levy, L. A. The Synthesis of 2,3,6,7 Tetrasubstituted Naphthalenes: 2,3,6,7 Tetrachloronaphthalene. Synth. Commun. 1983, 13, 639-648.
26. Guindon, Y.; Frenette, R.; Fortin, R.; Rokach, J. Direct Synthesis of Thio Ethers from Thiols and Alcohols. J. Org. Chem. 1983, 48, 1357-1359.
27. Zhang, X. P.; Ritke, M. K.; Yalowich, J. C.; Slovak, M. L.; Ho, J. P.; Collins, K. I.; Annable, T.; Arceci, R. J.; Greenberger, L. M. P-glycoprotein mediates profound resistance to bisantrene. Oncol. Res. 1994, 6, 291-301.
28. Data not shown.
29. Relling, M. V. Ther. Drug Monit. 1996, 18, 350-356.
30. Greenberger, L. M.; Collins, K. I.; Annable, T.; Boni, J. P.; May, M. K.; Lai, F. M.; Kramer, R.; Citerella, R. V.; Hallett, W. A.; Powell, D. CL 329,753: a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared to verapamil and cyclosporine A. Oncol. Res. 1996, 8, 207-218.
31. Colombo, T.; Zucchetti, M.; D'Incalci, M. Cyclosporine A markedly changes the distribution of doxorubicin in mice and rats. J. Pharmacol. Exp. Ther. 1994, 269, 22-27.
32. Gruber, A.; Peterson, C.; Reizenstein, P. D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. Int. J. Cancer 1988, 41, 224-226.
33. Höllt, V.; Kouba, M.; Dietel, M.; Vogt, G. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. Biochem. Pharmacol. 1992, 43, 2601-2608.
34. Mannhold, R. Calcium antagonists: basic chemical and pharacological properties. Drugs Today 1884, 20, 69-90.
35. Theodore, L. J.; Nelson, W. L. Stereospecific Synthesis of the Enantiomers of Verapamil and Gallopamil. J. Org. Chem. 1987, 52, 1309-1315.
36. Skehan, P.; Stornet, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.; Bokbosch, H.; Kenny, S.; Boyd, M. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
37. Ushujima, R.; Nakagawa, S.; Susumu, M. Isoindole derivatives, processes for their preparation, and their use as intermediates for cephalosporin intermediates. European Patent 227986; Chem. Abstr. 1987, 108, 186564.
38. Ruchirawat, S.; Chaisupakitsin, M.; Patranuwatana, N.; Cashaw, J. L.; Davis, V. E. A Convenient Synthesis of Simple Tetrahydroisoquinolines. Synth. Commun. 1984, 14, 1221-1228.
39. Skraup, Z. H. Über das Parachinanisol, Monatsh. Chem. 1885, 6, 760-770.
40. Chrisey, L. A.; Brossi, A. N,N′,N″-Tris(3′,4′,5′-trimethoxyphen-ethyl)-1,3,5- hexahydrotriazine, a methylenemescaline trimer: characterization and selective cyclization to anhalinine under nonaqueous conditions. Heterocycles 1989, 29, 1179-83.
41. Meyers, A. I.; Guiles, J. The Asymmetric Total Synthesis of (+)-Reticuline. Heterocycles 1989, 28, 295-301.
42. Bobbitt, J. M.; McNew-Kiely, J.; Khanna, K. L.; Ebermann, R. Synthesis of Isoquinolines III. A New Synthesis of 1,2,3,4-Tetrahydroisoquinolines. J. Org. Chem. 1965, 30, 2247-2250.
43. Regnier, G.; Gargouil, Y. M.; Vilaine, J. P. Preparation of [(quinolinylethyl)amino] valeronitriles as calcium channel blockers. French Patent 2588258; Chem. Abstr. 1987,108, 94409.
44. Newman, H. Preparation of verapamil-related benzeneaceto-nitriles as calcium channel blockers, and their therapeutic compositions. U.S. Patent 4833162; Chem. Abstr. 1989, 111, 173795.
45. Freudenberg, K.; Carrara, G.; Cohn, E. Eine Umlagerungsreaktion des Catechins. Liebigs Ann. Chem. 1925, 446, 94.
46. Millar, J. G.; Oehlschlager, A. C. Synthesis of Z,Z-Skipped Diene Macrolide Pheromones for Cryptolestes and Oryzaephilus Grain Beetles (Coleoptera Cucujidae). J. Org. Chem. 1984, 49, 2332-2338.